Clinical condition evaluation new system for predicting one-year joint destruction progress of rheumatoid arthritis patient

Abstract

The invention discloses a clinical condition evaluation new system for predicting a one-year joint destruction progress of a rheumatoid arthritis patient. According to the invention, a new index whichcan be used for predicting the one-year joint destruction progress of the rheumatoid arthritis patient is researched, namely a limb muscle index (ASMI), and the clinical condition evaluation new system for predicting the one-year joint destruction progress of the rheumatoid arthritis patient is established based on the limb muscle index. The system can accurately screen the high-risk patient, themiddle-risk patient and the low-risk patient in the one-year joint destruction progress earlier than prior art for nine months to one year, and different treatment plans are utilized for the high-risk patient, the middle-risk patient and the low-risk patient, thereby realizing intensive treatment of the high-risk patient and the middle-risk patient earlier for nine months to one year, guiding clinical medicine taking for more effectively reducing or blocking the joint destruction progress of the rheumatoid arthritis patient, preventing disability, and realizing important meaning and high value in treatment controlling and monitoring of rheumatoid arthritis.

Description

technical field [0001] The invention belongs to the field of medical technology. More specifically, it relates to a new clinical condition assessment system for predicting the 1-year progression of joint destruction in patients with rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis (RA) is a common chronic disabling disease characterized by progressive joint destruction, and it is the leading cause of physical disability in women in my country (accounting for 9.4%, according to the results of the second national sample survey of disabled people) . More than 70% of RA patients have joint erosion and destruction, about 90% of which occur in the first year of the disease, and 20% to 30% of patients lose their original working ability in the first 2 to 3 years of onset, and are directly used for RA every year The cost of treatment and the indirect economic loss caused by the disability of the patient's working ability are very huge. Therefore, controllin...

AI Technical Summary

Problems solved by technology

More than 70% of RA patients have joint erosion and destruction, about 90% of which occur in the first year of the disease, and 20% to 30% of patients lose their original working ability in the first 2 to 3 years of onset, and are directly used for RA every year The cost of treatment and the indirect economic loss caused by the disability of the patient's working ability are very huge

The above suggests that the disease activity score-based treatment recommended by the current guidelines cannot effectively prevent the progression of joint destruction in RA patients, especially those whose disease activity reaches the standard after treatment. There is an urgent need for new and more effective indicators to improve the RA disease assessment system in clinical practice. To guide therapy in order to more effectively reduce or block the progression of joint destruction in RA patients

Images